Epilepsi Tedavisinin Temel İlkeleri, Antinöbet Tedavi Başlama - Kesme Prensipleri

Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-2.

Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475-82.

Kim LG, Johnson TL, Marson AG, Chadwick DW; MRC MESS Study group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the mess trial. Lancet Neurol 2006;5:317-22.

Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014 Feb 28;348:g254. doi: 10.1136/bmj.g254. PMID: 24583319.

DiMario FJ Jr. Paroxysmal nonepileptic events of childhood. Semin Pediatr Neurol. 2006;13 (4):208-21.

Stephenson J, Whitehouse WP, Zuberi S. Paroxysmal nonepileptic disorders: Differential diagnosis of epilepsy. En: Wallace S, Farrell K, eds. Epilepsy in children. 2nd Edition. Arnold, London. 2004.p.4-20.

Fejerman N. Nonepileptic disorders imitating generalized idiopathic epilepsies. Epilepsia. 2005;46(9):80-3.

Orivoli S, Facini C, Pisani F. Paroxysmal nonepileptic motor phenomena in newborn. Brain Dev. 2015;37(9):833-9.

Canpolat M, Acer H, Kumandaş S. Nonepileptik paroksismal olaylar. Kumandaş S, Canpolat M, editörler. Çocukluk Çağı Epilepsileri. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.210-31.

Panayiotopoulos CD, A Clinical Guide to Epileptic Syndromes and Their Treatment, 2010. Springer Healthcare Ltd.

Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav 2009;15:56-65.

Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013;12:757-76.

Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553-64.

Abou-Khalil B, Schmidt D. Antiepileptic drugs: advantages and disadvantages. In: Stefan H, Theodore WH, eds. Handbook of clinical neurology. Vol 108. Epilepsy part II: treatment. Elsevier 2012:723-39.

Hirtz D, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, et al. Practice parameter: Treatment of the child with a first unprovoked seizure - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60(2): 166-75.

Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011;52:657-78.

Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010;88:260-6.

WHO. Disease control priorities related to mental, neurological, developmental and substance abuse disorders.2006. www.who.int/mental_health/publications/financing/disease_control_ priorities_mental_neurological_disorders/en/index.html

Editorial. Epilepsy must become a higher priority in Europe. Lancet Neurol 2010;9:941.

Abou-Khalil B, Schmidt D. Antiepileptic drugs: advantages and disadvantages. In: Stefan H, Theodore WH, eds. Handbook of clinical neurology. Vol 108. Epilepsy part II: treatment. Elsevier 2012:723-39.

Conway J, Kriel R, Birnbaum AJSK, Ashwal S, Ferriero DM. Pediatric Neurology: Principles, Mosby PteP. Antiepileptic drug therapy in children. 2006:1105-30.

Shinnar S, O’Dell C. Treatment decisions in childhood seizures. Pediatric epilepsy: diagnosis and therapy: Demos Publications, New York. 1993.p.215-21.

Crumrine PK. Antiepileptic drug selection in pediatric epilepsy. Journal of Child Neurology. 2002;17(2):2-8.

Jones KEA, Howells R, Mallick AA, Paul SP, Dey I. NICE guideline review: Epilepsies in children, young people and adults NG217. Arch Dis Child Educ Pract Ed. 2023 Dec;108(6):416-421. doi: 10.1136/archdischild-2022-324427. Epub 2023 Jun 20. PMID: 37339862.

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-521. doi: 10.1111/epi.13709. Epub 2017 Mar 8. PMID: 28276062; PMCID: PMC5386840.

Guerrini R, Zaccara G, la Marca G, Rosati A. Safety and tolerability of antiepileptic drug treatment in children with epilepsy. Drug Saf 2012;35:519-33.

Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009;50:1-23.

Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia2008;49:1239-76.

Camfield P, Camfield CJE. When is it safe to discontinue AED treatment. 2008;49:25-8.

Hixson JDJCtoin. Stopping antiepileptic drugs: when and why? 2010;12(5):434-42.

Strozzi ı, Nolan SJ, Sperling MR, Wingerchuk DM, Sirven J. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database of Systematic Reviews. 2015(2).

Güngör O, Canpolat M, Kumandaş S. Çocuklarda antiepileptik başlama ve kesme ilkeleri. Kumandaş S, Canpolat M, editörler. Çocukluk Çağı Epilepsileri. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.162-7.

Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: A meta-analysis. Neurology. 1997; (2):430-7.

Dryżałowski P, Jóźwiak S, Franckiewicz M, Strzelecka JJ Ninp. Benign epilepsy with centrotemporal spikes-Current concepts of diagnosis and treatment. 2018

Lossius Mı, Alfstad K, Aaberg KM, Nakken KOJTfdNltfpm, ny raekke. Discontinuation of antiepileptic drugs in seizure-free patients: when and how? 2017;137(6):451-4.

vorderwülbecke BJ, Kowski AB, Kirschbaum A, Merkle H, Senf P, Janz D, et al. Long-term outcome in adolescent-onset generalized genetic epilepsies. 2017;58(7):1244-50.

Das CP, Sawhney ıMS, Lal v, Prabhakar S. Risk of recurrence of seizures following single unprovoked idiopathic seizure. Neurology ındia. 2000;48(4):357-60.

American Academy of Neurology Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients-summary statement. Neurology 1996;47:600-2.

Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry 2011;82:1328-33.

Schmidt D, Baumgartner C, Löscher W. Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience. Epilepsia 2004;45:179-86.

Braun KP, Schmidt D. Stopping antiepileptic drugs in seizure-free patients. Curr Opin Neurol. 2014 Apr;27(2):219-26.

Zeng TF, An DM, Li JM, Li YH, Chen L, Hong Z, et al. Evaluation of different antiepileptic drug strategies in medically refractory epilepsy patients following epilepsy surgery. Epilepsy Res 2012;101:14-21.

Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007;130:334-45.

Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-2.

Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475-82.

Kim LG, Johnson TL, Marson AG, Chadwick DW; MRC MESS Study group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the mess trial. Lancet Neurol 2006;5:317-22.

Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014 Feb 28;348:g254. doi: 10.1136/bmj.g254. PMID: 24583319.

DiMario FJ Jr. Paroxysmal nonepileptic events of childhood. Semin Pediatr Neurol. 2006;13 (4):208-21.

Stephenson J, Whitehouse WP, Zuberi S. Paroxysmal nonepileptic disorders: Differential diagnosis of epilepsy. En: Wallace S, Farrell K, eds. Epilepsy in children. 2nd Edition. Arnold, London. 2004.p.4-20.

Fejerman N. Nonepileptic disorders imitating generalized idiopathic epilepsies. Epilepsia. 2005;46(9):80-3.

Orivoli S, Facini C, Pisani F. Paroxysmal nonepileptic motor phenomena in newborn. Brain Dev. 2015;37(9):833-9.

Canpolat M, Acer H, Kumandaş S. Nonepileptik paroksismal olaylar. Kumandaş S, Canpolat M, editörler. Çocukluk Çağı Epilepsileri. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.210-31.

Panayiotopoulos CD, A Clinical Guide to Epileptic Syndromes and Their Treatment, 2010. Springer Healthcare Ltd.

Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav 2009;15:56-65.

Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013;12:757-76.

Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553-64.

Abou-Khalil B, Schmidt D. Antiepileptic drugs: advantages and disadvantages. In: Stefan H, Theodore WH, eds. Handbook of clinical neurology. Vol 108. Epilepsy part II: treatment. Elsevier 2012:723-39.

Hirtz D, Berg A, Bettis D, Camfield C, Camfield P, Crumrine P, et al. Practice parameter: Treatment of the child with a first unprovoked seizure - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60(2): 166-75.

Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011;52:657-78.

Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010;88:260-6.

WHO. Disease control priorities related to mental, neurological, developmental and substance abuse disorders.2006. www.who.int/mental_health/publications/financing/disease_control_ priorities_mental_neurological_disorders/en/index.html

Editorial. Epilepsy must become a higher priority in Europe. Lancet Neurol 2010;9:941.

Abou-Khalil B, Schmidt D. Antiepileptic drugs: advantages and disadvantages. In: Stefan H, Theodore WH, eds. Handbook of clinical neurology. Vol 108. Epilepsy part II: treatment. Elsevier 2012:723-39.

Conway J, Kriel R, Birnbaum AJSK, Ashwal S, Ferriero DM. Pediatric Neurology: Principles, Mosby PteP. Antiepileptic drug therapy in children. 2006:1105-30.

Shinnar S, O’Dell C. Treatment decisions in childhood seizures. Pediatric epilepsy: diagnosis and therapy: Demos Publications, New York. 1993.p.215-21.

Crumrine PK. Antiepileptic drug selection in pediatric epilepsy. Journal of Child Neurology. 2002;17(2):2-8.

Jones KEA, Howells R, Mallick AA, Paul SP, Dey I. NICE guideline review: Epilepsies in children, young people and adults NG217. Arch Dis Child Educ Pract Ed. 2023 Dec;108(6):416-421. doi: 10.1136/archdischild-2022-324427. Epub 2023 Jun 20. PMID: 37339862.

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-521. doi: 10.1111/epi.13709. Epub 2017 Mar 8. PMID: 28276062; PMCID: PMC5386840.

Guerrini R, Zaccara G, la Marca G, Rosati A. Safety and tolerability of antiepileptic drug treatment in children with epilepsy. Drug Saf 2012;35:519-33.

Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009;50:1-23.

Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia2008;49:1239-76.

Camfield P, Camfield CJE. When is it safe to discontinue AED treatment. 2008;49:25-8.

Hixson JDJCtoin. Stopping antiepileptic drugs: when and why? 2010;12(5):434-42.

Strozzi ı, Nolan SJ, Sperling MR, Wingerchuk DM, Sirven J. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database of Systematic Reviews. 2015(2).

Güngör O, Canpolat M, Kumandaş S. Çocuklarda antiepileptik başlama ve kesme ilkeleri. Kumandaş S, Canpolat M, editörler. Çocukluk Çağı Epilepsileri. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.162-7.

Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: A meta-analysis. Neurology. 1997; (2):430-7.

Dryżałowski P, Jóźwiak S, Franckiewicz M, Strzelecka JJ Ninp. Benign epilepsy with centrotemporal spikes-Current concepts of diagnosis and treatment. 2018

Lossius Mı, Alfstad K, Aaberg KM, Nakken KOJTfdNltfpm, ny raekke. Discontinuation of antiepileptic drugs in seizure-free patients: when and how? 2017;137(6):451-4.

vorderwülbecke BJ, Kowski AB, Kirschbaum A, Merkle H, Senf P, Janz D, et al. Long-term outcome in adolescent-onset generalized genetic epilepsies. 2017;58(7):1244-50.

Das CP, Sawhney ıMS, Lal v, Prabhakar S. Risk of recurrence of seizures following single unprovoked idiopathic seizure. Neurology ındia. 2000;48(4):357-60.

American Academy of Neurology Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients-summary statement. Neurology 1996;47:600-2.

Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry 2011;82:1328-33.

Schmidt D, Baumgartner C, Löscher W. Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience. Epilepsia 2004;45:179-86.

Braun KP, Schmidt D. Stopping antiepileptic drugs in seizure-free patients. Curr Opin Neurol. 2014 Apr;27(2):219-26.

Zeng TF, An DM, Li JM, Li YH, Chen L, Hong Z, et al. Evaluation of different antiepileptic drug strategies in medically refractory epilepsy patients following epilepsy surgery. Epilepsy Res 2012;101:14-21.

Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007;130:334-45.